226 related articles for article (PubMed ID: 29274374)
21. Titania coated upconversion nanoparticles for near-infrared light triggered photodynamic therapy.
Lucky SS; Muhammad Idris N; Li Z; Huang K; Soo KC; Zhang Y
ACS Nano; 2015 Jan; 9(1):191-205. PubMed ID: 25564723
[TBL] [Abstract][Full Text] [Related]
22. Development and characterization of novel photosensitizer : scFv conjugates for use in photodynamic therapy of cancer.
Staneloudi C; Smith KA; Hudson R; Malatesti N; Savoie H; Boyle RW; Greenman J
Immunology; 2007 Apr; 120(4):512-7. PubMed ID: 17343613
[TBL] [Abstract][Full Text] [Related]
23. Photochemical targeting of epidermal growth factor receptor: a mechanistic study.
Savellano MD; Hasan T
Clin Cancer Res; 2005 Feb; 11(4):1658-68. PubMed ID: 15746071
[TBL] [Abstract][Full Text] [Related]
24. Near-infrared photoimmunotherapy with galactosyl serum albumin in a model of diffuse peritoneal disseminated ovarian cancer.
Harada T; Nakamura Y; Sato K; Nagaya T; Okuyama S; Ogata F; Choyke PL; Kobayashi H
Oncotarget; 2016 Nov; 7(48):79408-79416. PubMed ID: 27765903
[TBL] [Abstract][Full Text] [Related]
25. Photoinduced Endosomal Escape Mechanism: A View from Photochemical Internalization Mediated by CPP-Photosensitizer Conjugates.
Soe TH; Watanabe K; Ohtsuki T
Molecules; 2020 Dec; 26(1):. PubMed ID: 33374732
[TBL] [Abstract][Full Text] [Related]
26. [Specific folic-acid targeted photosensitizer. The first step toward intraperitoneal photodynamic therapy for epithelial ovarian cancer].
Azaïs H; Frochot C; Grabarz A; Khodja Bach S; Colombeau L; Delhem N; Mordon S; Collinet P
Gynecol Obstet Fertil Senol; 2017 Apr; 45(4):190-196. PubMed ID: 28359805
[TBL] [Abstract][Full Text] [Related]
27. Epidermal growth factor receptor (EGFR) density may not be the only determinant for the efficacy of EGFR-targeted photoimmunotherapy in human head and neck cancer cell lines.
Peng W; de Bruijn HS; Farrell E; Sioud M; Mashayekhi V; Oliveira S; van Dam GM; Roodenburg JLN; Witjes MJH; Robinson DJ
Lasers Surg Med; 2018 Jul; 50(5):513-522. PubMed ID: 29777587
[TBL] [Abstract][Full Text] [Related]
28. Photosensitizer-conjugated tryptophan-containing peptide ligands as new dual-targeted theranostics for cancers.
Kim J; Chae J; Kim JS; Goh SH; Choi Y
Int J Pharm; 2016 Nov; 513(1-2):584-590. PubMed ID: 27686051
[TBL] [Abstract][Full Text] [Related]
29. PCR-based approach for site-specific conjugation of long double-stranded DNA to a single-domain VHH antibody.
Akazawa-Ogawa Y; Komatsu Y; Nakajima Y; Kojima N; Hagihara Y
J Biochem; 2020 Jul; 168(1):63-72. PubMed ID: 32154894
[TBL] [Abstract][Full Text] [Related]
30. Potent and specific antitumor effect of CEA-targeted photoimmunotherapy.
Shirasu N; Yamada H; Shibaguchi H; Kuroki M; Kuroki M
Int J Cancer; 2014 Dec; 135(11):2697-710. PubMed ID: 24740257
[TBL] [Abstract][Full Text] [Related]
31. Two-Photon Photosensitizer-Polymer Conjugates for Combined Cancer Cell Death Induction and Two-Photon Fluorescence Imaging: Structure/Photodynamic Therapy Efficiency Relationship.
Cepraga C; Marotte S; Ben Daoud E; Favier A; Lanoë PH; Monnereau C; Baldeck P; Andraud C; Marvel J; Charreyre MT; Leverrier Y
Biomacromolecules; 2017 Dec; 18(12):4022-4033. PubMed ID: 29020442
[TBL] [Abstract][Full Text] [Related]
32. Photodynamic tumor eradication with a novel targetable photosensitizer: strong vascular effects and dependence on treatment repetition versus potentiation.
Savellano MD; Owusu-Brackett N; Son J; Ganga T; Leung NL; Savellano DH
Photochem Photobiol; 2013; 89(3):687-97. PubMed ID: 23145766
[TBL] [Abstract][Full Text] [Related]
33. Site-specific conjugation of single domain antibodies to liposomes enhances photosensitizer uptake and photodynamic therapy efficacy.
Broekgaarden M; van Vught R; Oliveira S; Roovers RC; van Bergen en Henegouwen PM; Pieters RJ; Van Gulik TM; Breukink E; Heger M
Nanoscale; 2016 Mar; 8(12):6490-4. PubMed ID: 26954515
[TBL] [Abstract][Full Text] [Related]
34. Photodynamic Therapy in the Treatment of Bladder Cancer: Past Challenges and Current Innovations.
Railkar R; Agarwal PK
Eur Urol Focus; 2018 Jul; 4(4):509-511. PubMed ID: 30145112
[TBL] [Abstract][Full Text] [Related]
35. Synergism of epidermal growth factor receptor-targeted immunotherapy with photodynamic treatment of ovarian cancer in vivo.
del Carmen MG; Rizvi I; Chang Y; Moor AC; Oliva E; Sherwood M; Pogue B; Hasan T
J Natl Cancer Inst; 2005 Oct; 97(20):1516-24. PubMed ID: 16234565
[TBL] [Abstract][Full Text] [Related]
36. Mono- and tri-cationic porphyrin-monoclonal antibody conjugates: photodynamic activity and mechanism of action.
Smith K; Malatesti N; Cauchon N; Hunting D; Lecomte R; van Lier JE; Greenman J; Boyle RW
Immunology; 2011 Feb; 132(2):256-65. PubMed ID: 21039468
[TBL] [Abstract][Full Text] [Related]
37. A novel photosensitizer: An l-glutamide lipid conjugate with improved properties for photodynamic therapy.
Nathan E; Vijayashree K; Harikrishna A; Takafuji M; Jintoku H; Ihara H; Rao NM
Photochem Photobiol Sci; 2016 Nov; 15(12):1476-1483. PubMed ID: 27874144
[TBL] [Abstract][Full Text] [Related]
38. Synthesis, bioanalysis and biodistribution of photosensitizer conjugates for photodynamic therapy.
St Denis TG; Hamblin MR
Bioanalysis; 2013 May; 5(9):1099-114. PubMed ID: 23641699
[TBL] [Abstract][Full Text] [Related]
39. Isolation of novel EGFR-specific VHH domains.
Gottlin EB; Xiangrong Guan ; Pegram C; Cannedy A; Campa MJ; Patz EF
J Biomol Screen; 2009 Jan; 14(1):77-85. PubMed ID: 19171923
[TBL] [Abstract][Full Text] [Related]
40. Variable Heavy Chain Domain Derived from a Cell-Penetrating Anti-DNA Monoclonal Antibody for the Intracellular Delivery of Biomolecules.
Im SW; Pravinsagar P; Im SR; Jang YJ
Immunol Invest; 2017 Jul; 46(5):500-517. PubMed ID: 28388234
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
